TNF and inflammatory bowel disease: Consistent with this theory, in our study, 34 of our 35 TNF inhibitor users were prescribed etanercept or adalimumab whereas in the inflammatory bowel disease study [15], 40% of the TNF inhibitor users were prescribed infliximab (F Caldera and M Hayney, University of Wisconsin-Madison, personal communication).